Heart Failure Rescued by Pharmacological Inhibition of Type 5 Adenylyl Cyclase

被引：0
|
作者：
Iwatsubo, Kosaku [1 ]
Baljinnyam, Erdene [1 ]
Lai, Lo [1 ]
Hong, Chull [1 ]
Gao, Shumin [1 ]
Yan, Lin [1 ]
Vatner, Dorothy [1 ]
Sadoshima, Junichi [1 ]
Vatner, Stephen [1 ]
Ishikawa, Yoshihiro [1 ]
机构：
[1] UMDNJ NJMS, Newark, NJ USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Heart failure; Drugs; Myocardial infarction; Beta-blocker; Apoptosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11285
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adenylyl Cyclase Type 5 Inhibition During Reperfusion Ameliorates Heart Failure Development
    Bravo, Claudio A.
    Yoon, Seonghun
    Kudej, Raymond K.
    Lee, Grace Jung Ah
    Park, Misun
    Tian, Yimin
    Vatner, Dorothy E.
    Yan, Lin
    Vatner, Stephen F.
    FASEB JOURNAL, 2013, 27
  • [2] Pharmacological Inhibition of Type 5 Adenylyl Cyclase Attenuates Functional Deterioration in Chronic Catecholamine Stress
    Iwatsubo, Kosaku
    Baljinnyam, Erdene
    Gao, Shumin
    Sadoshima, Junichi
    Vatner, Dorothy E.
    Vatner, Stephen F.
    Ishikawa, Yoshihiro
    CIRCULATION, 2008, 118 (18) : S542 - S542
  • [3] Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms.
    Onda, T
    Hashimoto, Y
    Nagai, M
    Kuramochi, H
    Saito, S
    Yamazaki, H
    Toya, Y
    Sakai, I
    Homcy, CJ
    Nishikawa, K
    Ishikawa, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) : 47785 - 47793
  • [4] Modulation of β-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5
    David Ho
    Lin Yan
    Kousaku Iwatsubo
    Dorothy E. Vatner
    Stephen F. Vatner
    Heart Failure Reviews, 2010, 15 : 495 - 512
  • [5] Modulation of β-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5
    Ho, David
    Yan, Lin
    Iwatsubo, Kousaku
    Vatner, Dorothy E.
    Vatner, Stephen F.
    HEART FAILURE REVIEWS, 2010, 15 (05) : 495 - 512
  • [6] Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase
    Iwatsubo, Kosaku
    Bravo, Claudio
    Uechi, Masami
    Baljinnyam, Erdene
    Nakamura, Takashi
    Umemura, Masanari
    Lai, Lo
    Gao, Shumin
    Yan, Lin
    Zhao, Xin
    Park, Misun
    Qiu, Hongyu
    Okumura, Satoshi
    Iwatsubo, Mizuka
    Vatner, Dorothy E.
    Vatner, Stephen F.
    Ishikawa, Yoshihiro
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (12): : H2622 - H2628
  • [7] Adenylyl cyclase type 5 is a new target of AMPK in the heart
    Garnier, A.
    Leroy, J.
    Delomenie, C.
    Mateo, P.
    Fortin, D.
    Imbeaud, S.
    Ichante, J. -L
    Delacroix, H.
    Viollet, B.
    Veksler, V.
    Ventura-Clapier, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 32 - 32
  • [8] Inhibition of Adenylyl Cyclase Type 5 Protects Against Obesity and Diabetes
    Ho, David
    Iwatsubo, Kosaku
    Yan, Lin
    De Lorenzo, Mariana
    Vatner, Dorothy E.
    Vatner, Stephen F.
    FASEB JOURNAL, 2011, 25
  • [9] Inhibition of Adenylyl Cyclase Type 5 Protects Against Obesity and Diabetes
    Ho, David
    Yan, Lin
    Zhao, Xin
    Gao, Shumin
    Iwatsubo, Kousaku
    Ishikawa, Yoshihiro
    Vatner, Dorothy E.
    Vatner, Stephen F.
    CIRCULATION, 2011, 124 (21)
  • [10] Adenylyl cyclase gene transfer in heart failure
    Hammond, H. Kirk
    INTERACTIVE AND INTEGRATIVE CARDIOLOGY, 2006, 1080 : 426 - 436
12345